2023’s best medtech innovations
Category: Best Medical Technology
Nominee: Organon’s Jada System
“The JADA System can provide visible and observable control of bleeding within minutes,” the company says on its website. “Low-level vacuum (80 mm Hg +/- 10 mm Hg, not to exceed 90 mm Hg) induces physiologic contraction of the uterus to control and treat abnormal postpartum uterine bleeding or hemorrhage.”
The FDA cleared the system in 2020 and cleared updates to the technology in 2021.
“More options in the area of maternal health for healthcare providers and women are urgently needed, which was what motivated Organon’s early acquisition of Jada,” Organon CEO Kevin Ali said in 2021. “Postpartum hemorrhage continues to be one of the most common complications of childbirth, and this recent FDA clearance supports our ability to continue providing healthcare providers this important option for treating women with abnormal postpartum bleeding.”